Lenacapavir — the twice-a-year injection shown to give near 100% protection — has landed in South Africa. Health officials call it a gamechanger, especially for young people and high-risk groups who struggle with daily pills. Nichola Lutchman from Gauteng health department says Gauteng is all set and ready.